Cargando…

Risk factors for drug therapy problems among Cambodian Americans with complex needs: a cross-sectional, observational study

BACKGROUND: Pharmaceutical drug therapy problems (DTPs) are a major public health problem. We examined patient-level risk factors for DTPs among Cambodian Americans. METHODS: Community health workers (CHWs) verbally administered surveys and completed a detailed medication review form with participan...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagner, Julie A., Bermudez-Millan, Angela, Berthold, S. Megan, Buckley, Thomas, Buxton, Orfeu M., Feinn, Richard, Kuoch, Theanvy, Kong, Sengly, Lim, Mackenzie, Polomoff, Christina, Scully, Mary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Routledge 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788352/
https://www.ncbi.nlm.nih.gov/pubmed/35087696
http://dx.doi.org/10.1080/21642850.2021.2021917
Descripción
Sumario:BACKGROUND: Pharmaceutical drug therapy problems (DTPs) are a major public health problem. We examined patient-level risk factors for DTPs among Cambodian Americans. METHODS: Community health workers (CHWs) verbally administered surveys and completed a detailed medication review form with participants. A doctoral-level pharmacist reviewed the form with the patient and CHW to determine DTP number and type (appropriateness, effectiveness, safety, and adherence). RESULTS: Participants (n = 63) averaged 55 years old, 6 years of education, 52% were married, 87% spoke Khmer at home, with modal household income <$20,000 (41%). The percentage of participants with DTPs was: 45% appropriateness, 25% effectiveness, 64% safety, and 30% adherence, averaging 3.7 DTPs per patient. In multiple regressions, patient characteristics uniquely predicted each type of DTP. In a multiple regression controlling for number of medications, being married reduced total DTPs (IRR = 0.70) and being depressed increased total DTPs (IRR = 1.26). CONCLUSIONS: Vulnerable patients should be prioritized for pharmacist/CHW teams to identify DTPs. Trial registration: ClinicalTrials.gov identifier: NCT02502929.